Skip to main content

Defendant Fact Sheet Chartered For Bard Hernia Mesh Lawsuits

Defendant Fact Sheet Chartered For Bard Hernia Mesh Lawsuits

Defendant Fact Sheet Chartered For Bard Hernia Mesh Lawsuits

Introduction

According to an order issued on April 1, the federal court overseeing the hernia mesh injury claims, targeted at C.R. Bard's polypropylene products, established protocols associated with the handling of Defendant Fact Sheets (DFS) for all cases included in the litigation's bellwether trial pool.

The order stated DFS for 12 cases must be submitted to the court on or prior to April 25, 2019. However, the order also specified defendants could request a 7-day extension for submitting a form, which the plaintiffs cannot withhold without a specific reason. Additionally, the order outlined procedures to resolve disputes when Plaintiffs’ Counsel claims a DFS to be insufficient, and the steps they must follow when a defendant fails to submit a completed form before the deadline expires. All information disclosed in a DFS, the form itself, and all related documents (including healthcare information) will be kept confidential as per the order. Last month, 12 lawsuits were shortlisted to be included in the bellwether trial pool, the court will shortlist three lawsuits among them for early trials in May 2020. These lawsuits will act as a representative case, the outcome of which will provide insight into how different jurors might rule in similar lawsuits filed over complications linked to Bard polypropylene hernia mesh.

There are more than 240 Bard hernia mesh lawsuits pending in the multidistrict litigation (MDL No. 2846; In Re:  Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation) formed in the Southern District of Ohio.

Earlier, Judge Edmund A. Sargus who is overlooking all the Bard hernia mesh lawsuits issued a pretrial order in a press conference. The order included a prediction from the plaintiffs' lawyers stating that the manufacturer will face roughly 3,000 claims in the federal MDL by the end of 2019. Another status conference is scheduled for April 17, 2019, for further discussion between the parties.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.